Dr. Geraghty’s primary areas of clinical practice and research focus have been limb preservation, dialysis access, and cerebrovascular disease. He has served as national/global principal investigator for multiple IDE trials including the VIBRANT, Lutonix BTK, Intact Vascular TOBA II Below The Knee, Boston Scientific SAVAL, and InspireMD C-Guardians II and III trials. Dr. Geraghty is co-director of the multidisciplinary Limb Preservation Program at Washington University Medical School. Dr. Geraghty is a Past President of the Midwestern Vascular Surgical Society and a Distinguished Fellow of the Society for Vascular Surgery. He has served as chair of the SVS Technology Assessment Committee and member of the SVS Lower Extremity Practice Guidelines Writing Group, Global Vascular Guidelines Writing Group, Popliteal Aneurysm Guidelines Writing Group, and SVS Strategic Board of Directors.